{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:38:57Z","timestamp":1787503137874,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jmgm.2018.02.017","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T01:19:33Z","timestamp":1520471973000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Rational approach to identify newer caspase-1 inhibitors using pharmacophore based virtual screening, docking and molecular dynamic simulation studies"],"prefix":"10.1016","volume":"81","author":[{"given":"Shivani","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palmi","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Chhabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2018.02.017_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a008656","article-title":"Caspase functions in cell death and disease","volume":"5","author":"McIlwain","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jmgm.2018.02.017_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2012.86","article-title":"Caspase-1: is IL-1 just the tip of the ICEberg?","volume":"3","author":"Denes","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jmgm.2018.02.017_bib3","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jmgm.2018.02.017_bib4","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1517\/13543784.10.7.1207","article-title":"ICE\/Caspase-1 inhibitors as novel anti-inflammatory drugs","volume":"10","author":"Randle","year":"2001","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.jmgm.2018.02.017_bib5","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/ard.61.11.960","article-title":"Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases","volume":"61","author":"Hallegua","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jmgm.2018.02.017_bib6","doi-asserted-by":"crossref","first-page":"32608","DOI":"10.1074\/jbc.273.49.32608","article-title":"Inhibition of human caspases by peptide-based and macromolecular inhibitors","volume":"273","author":"Garcia-Calvo","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jmgm.2018.02.017_bib7","first-page":"154","article-title":"Pralnacasan (vertex pharmaceuticals)","volume":"6","author":"Siegmund","year":"2003","journal-title":"Idrugs"},{"key":"10.1016\/j.jmgm.2018.02.017_bib8","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.4049\/jimmunol.175.4.2630","article-title":"IL converting enzyme\/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients","volume":"175","author":"Stack","year":"2005","journal-title":"J.\u00a0Immunol."},{"issue":"5","key":"10.1016\/j.jmgm.2018.02.017_bib9","first-page":"568","article-title":"The potential for caspases in drug discovery","volume":"13","author":"MacKenzie","year":"2010","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.jmgm.2018.02.017_bib10","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1016\/j.bmcl.2005.06.046","article-title":"Synthesis and evaluation of tricyclic pyrrolopyrimidinones as dipeptide mimetics: inhibition of interleukin-1b-converting enzyme","volume":"15","author":"Laufersweiler","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2018.02.017_bib11","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1016\/j.bmcl.2006.07.016","article-title":"Synthesis and evaluation of thiazepines as interleukin-1b converting enzyme (ICE) inhibitors","volume":"16","author":"Ellis","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2018.02.017_bib12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.bmc.2006.11.011","article-title":"Synthesis and evaluation of unsaturated caprolactams as interleukin-1b converting enzyme (ICE) inhibitors","volume":"15","author":"Wang","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2018.02.017_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bmcl.2003.10.065","article-title":"The design and synthesis of sulfonamides as caspase-1 inhibitors","volume":"14","author":"Harter","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2018.02.017_bib14","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.1016\/j.bmc.2006.07.056","article-title":"Synthesis and evaluation of novel 8,5-fused bicyclic peptidomimetic compounds as interleukin-1b converting enzyme (ICE) inhibitors","volume":"14","author":"Soper","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2018.02.017_bib15","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1016\/j.bmcl.2005.06.050","article-title":"Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1b synthesis","volume":"15","author":"Oppong","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jmgm.2018.02.017_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcc.540160205","article-title":"Poling: promoting conformational variation","volume":"16","author":"Smellie","year":"1995","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2018.02.017_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"CHARMM: a program for macromolecular energy, minimization, and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.jmgm.2018.02.017_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1747-0285.2012.01384.x","article-title":"Discovery of novel acyl coenzyme a: cholesterol acyltransferase inhibitors: pharmacophore-based virtual screening, synthesis and pharmacology","volume":"80","author":"Chhabria","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2018.02.017_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/ci049731z","article-title":"Comparison of conformational analysis techniques to generate pharmacophore hypotheses using catalyst","volume":"45","author":"Kristam","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2018.02.017_bib20","series-title":"HypoGen: an Automated System for Generating 3D Predictive Pharmacophore Models","author":"Li","year":"2000"},{"key":"10.1016\/j.jmgm.2018.02.017_bib21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/07391102.2015.1077343","article-title":"Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design","volume":"34","author":"Athar","year":"2016","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2018.02.017_bib22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11030-015-9591-5","article-title":"Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase","volume":"19","author":"Amaravadhi","year":"2015","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2018.02.017_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jmgm.2017.07.005","article-title":"Identification of Mycobacterium tuberculosis enoyl-acyl Carrier protein reductase inhibitors: a combined in-silico and in-vitro analysis","volume":"76","author":"Lone","year":"2017","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2018.02.017_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u2013a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2018.02.017_bib25","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.4103\/0973-1296.157670","article-title":"Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery","volume":"11","author":"Kumar","year":"2015","journal-title":"Phcog. Mag."},{"key":"10.1016\/j.jmgm.2018.02.017_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cbi.2016.06.011","article-title":"Multi-level structure-based pharmacophore modelling of caspase-3-non-peptide complexes: extracting essential pharmacophore features and its application to virtual screening","volume":"254","author":"Kumar","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.jmgm.2018.02.017_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/qsar.200730051","article-title":"Benchmarking the reliability of QikProp. Correlation between experimental and predictedvalues","volume":"27","author":"Ioakimidis","year":"2008","journal-title":"QSAR Comb. Sci."},{"key":"10.1016\/j.jmgm.2018.02.017_bib28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bmcl.2005.10.048","article-title":"Tethering identifies fragment that yields potent inhibitors of human caspase-1","volume":"16","author":"Fahr","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2018.02.017_bib29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nsb0796-619","article-title":"The three-dimensional structure of apopain\/CPP32, a key mediator of apoptosis","volume":"3","author":"Rotonda","year":"1996","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.jmgm.2018.02.017_bib30","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1111\/j.1742-4658.2007.05994.x","article-title":"Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis","volume":"274","author":"Agniswamy","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.jmgm.2018.02.017_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/jmbi.2000.4041","article-title":"Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex","volume":"302","author":"Blanchard","year":"2000","journal-title":"J.\u00a0Mol. Biol."},{"issue":"3","key":"10.1016\/j.jmgm.2018.02.017_bib32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11030-012-9387-9","article-title":"A\u00a0rational approach to selective pharmacophore designing: an innovative strategy for specific recognition of Gsk3\u03b2","volume":"16","author":"Pradeep","year":"2012","journal-title":"Mol. Divers."},{"issue":"4","key":"10.1016\/j.jmgm.2018.02.017_bib33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s11030-014-9543-5","article-title":"An in silico protocol for identifying mTOR inhibitors from natural products","volume":"18","author":"Chen","year":"2014","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2018.02.017_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jmgm.2016.09.008","article-title":"A\u00a0mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking,density functional and molecular dynamics simulation study","volume":"70","author":"Choubey","year":"2016","journal-title":"J.\u00a0Mol. Graph. Model."},{"issue":"2","key":"10.1016\/j.jmgm.2018.02.017_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11030-013-9497-z","article-title":"Dual inhibitors of Janus kinase 2 and 3 (JAK2\/3): designing by pharmacophore- and docking-based virtual screening approach","volume":"18","author":"Jasuja","year":"2014","journal-title":"Mol. Divers."},{"key":"10.1016\/j.jmgm.2018.02.017_bib36","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jmgm.2018.02.017_bib37","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2174\/1568026614666140929151140","article-title":"Virtual screening and discovery of novel Aurora kinase inhibitors","volume":"14","author":"Raghu","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jmgm.2018.02.017_bib38","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2018.02.017_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jmgm.2015.11.004","article-title":"A\u00a0systematic methodology for large scale compound screening: a case study on the discovery of novel S1PL inhibitors","volume":"63","author":"Deniz","year":"2016","journal-title":"J.\u00a0Mol. Graph. Model."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317307830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317307830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:57:34Z","timestamp":1761080254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326317307830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":39,"alternative-id":["S1093326317307830"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.02.017","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational approach to identify newer caspase-1 inhibitors using pharmacophore based virtual screening, docking and molecular dynamic simulation studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2018.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}